New prize for cancer research
The BEUG FOUNDATION FOR METASTASIS RESEARCH is accepting applications for the METASTASIS PRIZE. Scientists are still trying to understand how cancer spreads from the place where it first arises to other locations in the body, a process that can have dramatic consequences for the health of cancer patients. The Metastasis Prize is meant to encourage and help introduce new approaches to impede cancer metastasis.
The Metastasis Prize is awarded in memory of Hartmut Beug and his efforts to understand the causes of cancer and how it spreads in the body. In the 1970s and 1980s, Beug identified new pairs of oncogenes in avian oncogenic viruses while working at the German Cancer Research Center (DFKz) and the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany. He was among the first scientists to put forward the idea that the transformation of hematopoietic cells into cancer cells requires the cooperation of growth factor signaling pathways and the deregulation of transcription. Beug later moved to the Institute for Molecular Pathology (IMP) in Vienna, Austria, to continue his research. He became a member of EMBO in 1983. The importance of how groups of oncogenes interact to bring about the development and spread of cancer was a consistent theme of his later work.
The 2013 Metastasis Prize will be awarded to a scientist who presents an original project on cancer metastasis. The prize provides financial assistance to obtain the preliminary data that could help to attract further support from institutions or companies interested in developing new approaches to restrict metastasis. Proposals should be submitted by 25 March 2013.
Further details and instructions for how to apply are available at www.beugstiftung-metastase.org